The Onus of Sphingolipid Enzymes in Cancer Drug Resistance.

Morad, Samy A F; Cabot, Myles C

Morad, Samy A F; Cabot, Myles C.

Afiliação

Morad SAF; Department of Pharmacology, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt.
Cabot MC; Department of Biochemistry and Molecular Biology, East Carolina University, Brody School of Medicine, and the East Carolina Diabetes and Obesity Institute, Greenville, SC, United States.

Adv Cancer Res ; 140: 235-263, 2018.

Article em En | MEDLINE | ID: mdl-30060811

Assuntos

Antineoplásicos/farmacologia; Ceramidas/metabolismo; Resistencia a Medicamentos Antineoplásicos; Enzimas/metabolismo; Neoplasias/enzimologia; Neoplasias/patologia; Esfingolipídeos/metabolismo; Animais; Apoptose; Humanos; Neoplasias/tratamento farmacológico

Palavras-chave

Ceramide; Chemotherapy (drug) resistance; Glucosylceramide synthase; Sphingolipid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Ceramidas / Resistencia a Medicamentos Antineoplásicos / Enzimas / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google